The medtech company Onward, listed on Euronext Brussels, has launched its commercial rollout in the U.S. and is now attracting significant interest. Sales of its ARC-EX system are expected to accelerate, following the sale of 10 systems in the first quarter. Meanwhile, the company continues…
Francis Muyshondt18 June 2025